Viewing Study NCT05411757


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-04-17 @ 12:18 AM
Study NCT ID: NCT05411757
Status: UNKNOWN
Last Update Posted: 2022-06-09
First Post: 2022-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer
Sponsor: Shandong Public Health Clinical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module